Does INVEGA SUSTENNA Cause Injection site nodule? 19 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Injection site nodule have been filed in association with INVEGA SUSTENNA. This represents 2.9% of all adverse event reports for INVEGA SUSTENNA.
19
Reports of Injection site nodule with INVEGA SUSTENNA
2.9%
of all INVEGA SUSTENNA reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site nodule From INVEGA SUSTENNA?
Of the 19 reports, 1 (5.3%) required hospitalization.
Is Injection site nodule Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INVEGA SUSTENNA. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does INVEGA SUSTENNA Cause?
Drug dose omission (98)
Drug ineffective (58)
Inappropriate schedule of drug administration (39)
Weight increased (34)
Blood prolactin increased (27)
Galactorrhoea (25)
Injection site mass (20)
Injection site pain (19)
Investigation (17)
Off label use (17)
What Other Drugs Cause Injection site nodule?
EXENATIDE (2,167)
HYDROXYPROGESTERONE CAPROATE (425)
ADALIMUMAB (364)
PALIPERIDONE (313)
DUPILUMAB (271)
BYDUREON (241)
ETANERCEPT (215)
CABOTEGRAVIR (178)
NALTREXONE (154)
CABOTEGRAVIR\RILPIVIRINE (153)
Which INVEGA SUSTENNA Alternatives Have Lower Injection site nodule Risk?
INVEGA SUSTENNA vs INVESTIGATIONAL BIOSIMILARS
INVEGA SUSTENNA vs INVESTIGATIONAL PRODUCT
INVEGA SUSTENNA vs INVOKANA
INVEGA SUSTENNA vs IOBENGUANE I-131
INVEGA SUSTENNA vs IOBITRIDOL